Freeport-McMoRan, Inc. vs Ecolab Inc. — Stock Comparison
Q·Score Breakdown
8.4
Buy
Overall
6.8
Hold
Quality
Health
Growth
Valuation
Sentiment
FCX
Clean balance sheet with low leverage (0.3× debt-to-equity).
ECL
High-quality business with 22% return on equity and 13% profit margins.
⚠ balance sheet warrants attention.
Analyst Consensus
BUY
Target $67.90 (+18.1%)
21 analysts
BUY
Target $317.48 (+21.7%)
21 analysts
Fundamentals
FCX
ECL
30.4×
Trailing P/E
35.8×
15.5×
Forward P/E
27.2×
10.3%
Profit Margin
12.8%
37.1%
Gross Margin
44.4%
15.6%
ROE
22.4%
8.8%
Revenue Growth
10.0%
154.0%
Earnings Growth
7.8%
1.47
Beta
1.02
—
Price / Book
—
$82.5B
Market Cap
$73.7B
$35 – $71
52-Week Range
$249 – $309
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.